Kostiukova N, Fishchuk L, Rossokha Z, Medvedieva N, Andreieva S, Bloshchinska S, et al. CYP2C19*2 gene variant (G681A, rs4244285) as a prognostic marker for the clinical course of multiple myeloma. Exp. oncol. [Internet]. 2023 May 26 [cited 2025 Nov. 26];43(4):336-40. Available from: https://exp-oncology.com.ua/index.php/Exp/article/view/2021-4-7